A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cemiplimab
Related studies linked through entity extraction aliases.
Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Hyperprogression in PD-L1 ≥ 50% NSCLC: a Biomarker Guided Phase 2 Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Randomized Phase II Trial of Cemiplimab Plus OSE2101 ( TEDOPI®) as Maintenance Therapy in ctDNA Positive NSCL. The Cemited Study.
- Status
- RECRUITING
- Phase
- PHASE2
Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
- Status
- RECRUITING
- Phase
- PHASE2
A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2